Healthcare EU Healthcare Predictions and Outlook, 2020

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
20-Feb-2020
REGION
Europe
DELIVERABLE TYPE
Market Outlook

RESEARCH CODE
MEE1-01-00-00-00
SKU
HC03266-EU-MO_24121
Yes
SHARE

EU Healthcare Predictions and Outlook, 2020
Published on: 20-Feb-2020 | SKU: HC03266-EU-MO_24121

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national healthcare policies and regulatory reforms that must re-invigorate future strategies. Social Determinants of Health (SDOH) will emerge as a big theme across progressive health systems as they seek to proactively engage patients and improve health outcomes that would help healthcare organizations meet quality standards.

This decade will bring significant changes and disruptions when it comes to digital-service-enabled health. Health and care delivery, as well as prevention in the 2020s, will become more consumer-centric, with AI-powered tools and virtual interactions between patients and care providers becoming the new normal in many situations. Data-driven interoperability and personalized diagnostics will accelerate the delivery of predictive-analysis-driven precision care. This will pave the way for better and efficient decision making for the patient and the provider and further drive partnerships between big tech companies that design care delivery models and healthcare organizations.

This follows the new vision for healthcare for 2020 and beyond, focusing not only on access, quality, and affordability but also on predictive, preventive, and outcome-based care models that promote social and financial inclusion. In 2020, consumer-driven models of healthcare will gain more market traction, as they stand to better bridge the gap of what consumers want and what healthcare can deliver.

Central and Eastern Europe is highly fragmented and is emerging as quite an attraction to healthcare investors. Screening services are facilitating better diagnosis of chronic conditions. The rise in disposable income and in healthcare spending is because of the presence of a rapidly aging population and their demand for better healthcare. Economic factors are also at play, with rising wages and disposable incomes freeing up personal money for healthcare-related spending. With the recent rise in minimum wages in Hungary and other recent reforms in various parts of Central and Eastern Europe, the economy in CEE and a parallel drop in unemployment rates are ideal for market participants.

Market Scope

Geographic Segmentation

Key Questions This Study Will Answer

Top Predictions for the EU Healthcare Industry, 2020

EU Healthcare Industry Forecast by Segment

EU Regional Performance Matrix

Revenue by Region

Prediction#1: By 2020, Orphan Drug R&D Pipeline will Surpass Non-orphan Drug to Account for 55% of the Total Pipeline Value

Prediction#2: Europe will Expand Biomanufacturing Capacity by ~15% to Reach a Market Share of 35% by 2020

Prediction#3: 2020 will be an Inflexion Point for Artificial Intelligence in Europe

Prediction#4: Hospital Cost Saving is Set to Increase by 25%–35% by 2020 as 15%–20% of ORs become Integrated

Prediction#5: POCT Market for Infectious Diseases will Breach the One-billion-dollar Mark in 2020

Prediction#6: Europe will Lead the Global IVF Market in 2020 and Account for 40% of Market Share

Prediction#7: The Demand for Precision Care Procedures will Fuel RASD to Reach $430 million by 2020 and Cut Complication Rates by 10%–15%

Prediction#8: Next-gen Imaging Equipment is set to Yield Annual Operational Savings of 10%–12%

Prediction#9: Medical-grade remote patient monitoring will witness a 15% growth

Prediction#10: Up to 20 New Enterprise-customer Partnerships will Redefine New Business Models

Top Pharmaceuticals and Biotechnology Growth Opportunities

Top Medical Technologies Growth Opportunities

Top Medical Imaging Equipment Growth Opportunities

Top In-Vitro Diagnostics Growth Opportunities

Top Healthcare IT Growth Opportunities

Companies to Watch Out For

Companies to Watch Out for (continued)

Healthcare IT

Medical Technologies

Medical Imaging Equipment

Pharmaceutical & Biotechnology

In-Vitro Diagnostics

UK and Europe’s Interdependencies that Support the Care Continuum

Select Indicators for Health System Assessment

Potential Disruption Across the UK Healthcare Sector

Critical Success Factors

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national healthcare policies and regulatory reforms that must re-invigorate future strategies. Social Determinants of Health (SDOH) will emerge as a big theme across progressive health systems as they seek to proactively engage patients and improve health outcomes that would help healthcare organizations meet quality standards. This decade will bring significant changes and disruptions when it comes to digital-service-enabled health. Health and care delivery, as well as prevention in the 2020s, will become more consumer-centric, with AI-powered tools and virtual interactions between patients and care providers becoming the new normal in many situations. Data-driven interoperability and personalized diagnostics will accelerate the delivery of predictive-analysis-driven precision care. This will pave the way for better and efficient decision making for the patient and the provider and further drive partnerships between big tech companies that design care delivery models and healthcare organizations. This follows the new vision for healthcare for 2020 and beyond, focusing not only on access, quality, and affordability but also on predictive, preventive, and outcome-based care models that promote social and financial inclusion. In 2020, consumer-driven models of healthcare will gain more market traction, as they stand to better bridge the gap of what consumers want and what healthcare can deliver. Central and Eastern Europe is highly fragmented and is emerging as quite an attraction to healthcare investors. Screening services are facilitating better diagnosis of chronic conditions. The rise in disposable income and in healthcare spending is because of the presence of a rapidly aging population and their demand for better healthcare. Economic factors are also at play, with rising wages and disposable incomes freeing up personal money for healthcare-related spending. With the recent rise in minimum wages in Hungary and other recent reforms in various parts of Central and Eastern Europe, the economy in CEE and a parallel drop in unemployment rates are ideal for market participants. Author: Bejoy Daniel
More Information
Deliverable Type Market Outlook
No Index No
Podcast No
Author Bejoy Daniel
Industries Healthcare
WIP Number MEE1-01-00-00-00
Is Prebook No
GPS Codes 9575-B1,9600-B1,9612-B1,9570-B1,9571-B1,9573-B1,9A48-B1,9A4B-B1,9611-B1,9614-B1,9627-B1

EU Healthcare Predictions and Outlook, 2020

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03266-EU-MO_24121